Skip to main content

Drug Interactions between cisplatin and torsemide

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

CISplatin torsemide

Applies to: cisplatin and torsemide

GENERALLY AVOID: The concomitant use of loop diuretics with cisplatin may increase the risk of ototoxicity. Loop diuretics, especially ethacrynic acid and high doses of furosemide, and cisplatin have been individually associated with ototoxicity.

MANAGEMENT: This combination should be avoided unless the potential benefit outweighs the risk. Audiometric testing is recommended if these drugs are given concurrently. Patients should be advised to promptly notify their physician if they experience hearing loss or tinnitus.

References (6)
  1. Komune S, Snow JB (1981) "Potentiating effects of cisplatin and ethacrynic acid in ototoxicity." Arch Otolaryngol, 107, p. 594-7
  2. Rhodes T, Twentyman PR (1992) "A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines." Br J Cancer, 65, p. 684-90
  3. (2001) "Product Information. Edecrin (ethacrynic acid)." Merck & Co., Inc
  4. Brock PR, Knight KR, Freyer DR, et al. (2012) "Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale." J Clin Oncol, 30, p. 2408-17
  5. Parsons SK, Neault MW, Lehmann, et al. (1998) "Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma." Bone Marrow Transplant, 22, p. 669-74
  6. Langer T, am Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O (2013) "Understanding platinum-induced ototoxicity." Trends Pharmacol Sci, 34, p. 458-69

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer